Study of safety, tolerability and efficacy of MK0493 in obese patients

Trial Profile

Study of safety, tolerability and efficacy of MK0493 in obese patients

Completed
Phase of Trial: Phase II

Latest Information Update: 02 Aug 2007

At a glance

  • Drugs MK 0493 (Primary)
  • Indications Obesity
  • Focus Therapeutic Use
  • Sponsors Merck & Co
  • Most Recent Events

    • 02 Aug 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top